NCT06495424 - Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 14, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Peripheral Diabetic NeuropathyPainful Diabetic Neuropathy

Interventions

DRUG

Capsaicin 8%

Repeat applications every 12 weeks in patients with PDPN of the feet.

Trial Locations (13)

17601

RECRUITING

Center for Interventional Pain and Spine, Lancaster

19010

RECRUITING

Center for Interventional Pain and Spine, Bryn Mawr

19034

RECRUITING

Center for Interventional Pain and Spine, Fort Washington

19808

RECRUITING

Center for Interventional Pain and Spine, Wilmington

30143

RECRUITING

Horizon Clinical Research, Jasper

30265

RECRUITING

Horizon Clinical Research, Newnan

30501

RECRUITING

Horizon Clinical Research, Gainesville

41017

RECRUITING

Iqra Research, Edgewood

95404

RECRUITING

Pacific Research Institute, Santa Rosa

95407

RECRUITING

Pacific Research Institute, Santa Rosa

95453

RECRUITING

Pacific Research Institute, Lakeport

95476

RECRUITING

Pacific Research Institute, Sonoma

07649

RECRUITING

Curalta Clinical Trials, Oradell